Literature DB >> 2808659

On the nature of memory disturbance in multiple sclerosis.

S M Rao1, G J Leo, P St Aubin-Faubert.   

Abstract

Thirty-seven patients with multiple sclerosis (MS) were compared to 26 normal controls of equivalent age, education, and verbal intelligence on measures of verbal learning and memory (Digit Span and Supraspan, Brown-Peterson Distractor Task, Selective Reminding Test, Story Recall, and Free Verbal Recall) and verbal fluency (Letter and Animal Fluency). The MS patients exhibited deficits on measures of secondary (long-term) memory and verbal fluency, but performed normally on measures of primary (short-term) memory, recognition memory, and rate of forgetting from secondary memory. These results suggest that the memory disturbance in MS results primarily from an imparied ability to access information from secondary memory, while encoding and storage capacity is intact. Degree of memory impairment was unrelated to length of illness, severity of disability, or self-reported depression.

Entities:  

Mesh:

Year:  1989        PMID: 2808659     DOI: 10.1080/01688638908400926

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  26 in total

1.  Altered functional adaptation to attention and working memory tasks with increasing complexity in relapsing-remitting multiple sclerosis patients.

Authors:  Michael Amann; Lea Sybil Dössegger; Iris-Katharina Penner; Jochen Gunther Hirsch; Carla Raselli; Pasquale Calabrese; Katrin Weier; Ernst-Wilhelm Radü; Ludwig Kappos; Achim Gass
Journal:  Hum Brain Mapp       Date:  2010-11-12       Impact factor: 5.038

2.  Memory impairment in multiple sclerosis is due to a core deficit in initial learning.

Authors:  John Deluca; Victoria M Leavitt; Nancy Chiaravalloti; Glenn Wylie
Journal:  J Neurol       Date:  2013-07-06       Impact factor: 4.849

3.  Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.

Authors:  Ranjan Dutta; Ansi Chang; Mary K Doud; Grahame J Kidd; Michael V Ribaudo; Elizabeth A Young; Robert J Fox; Susan M Staugaitis; Bruce D Trapp
Journal:  Ann Neurol       Date:  2011-03       Impact factor: 10.422

4.  The less BOLD, the wiser: support for the latent resource hypothesis after traumatic brain injury.

Authors:  John D Medaglia; Kathy S Chiou; Julia Slocomb; Neal M Fitzpatrick; Britney M Wardecker; Deepa Ramanathan; Jeffrey Vesek; David C Good; Frank G Hillary
Journal:  Hum Brain Mapp       Date:  2011-05-17       Impact factor: 5.038

5.  Verbal episodic memory in 426 multiple sclerosis patients: impairment in encoding, retrieval or both?

Authors:  H Brissart; E Morele; C Baumann; M Debouverie
Journal:  Neurol Sci       Date:  2012-01-13       Impact factor: 3.307

6.  Deconstructing spatial working memory and attention deficits in multiple sclerosis.

Authors:  Leon Gmeindl; Susan M Courtney
Journal:  Neuropsychology       Date:  2011-11-07       Impact factor: 3.295

7.  The role of the thalamus and hippocampus in episodic memory performance in patients with multiple sclerosis.

Authors:  Katherine A Koenig; Stephen M Rao; Mark J Lowe; Jian Lin; Ken E Sakaie; Lael Stone; Robert A Bermel; Bruce D Trapp; Micheal D Phillips
Journal:  Mult Scler       Date:  2018-03-07       Impact factor: 6.312

8.  Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images.

Authors:  D M Moriarty; A J Blackshaw; P R Talbot; H L Griffiths; J S Snowden; V F Hillier; S Capener; R D Laitt; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

Review 9.  Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).

Authors:  R A Asherson; S D Denburg; J A Denburg; R M Carbotte; N Futrell
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

10.  Working memory impairment among persons with chronic progressive multiple sclerosis.

Authors:  J Grigsby; S D Ayarbe; N Kravcisin; D Busenbark
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.